We had an exciting year, including partnering with Certara, winning Data Solution of the Year, and releasing TrialAssure LINK. Here’s a look back at 2021.
Certara Adopts TrialAssure ANONYMIZE Solution to Speed Life Science Industry Need to Meet Regulatory Requirements for Data Sharing
Certara, the leading global leader in biosimulation, has licensed TrialAssure’s ANONYMZE software to anonymize clinical data. Through this collaboration, Certera’s regulatory science division, Synchrogenix, will utilize TrialAssure ANONYMIZE in a software-as-a-service (SaaS) model to provide a tech-enabled Anonymization service for their client roster of more than 1,650 global biopharmaceutical and biotech companies across 61 counties.
TrialAssure’s Transparency Suite Named Data Solution of the Year for the Second Consecutive Year
TrialAssure won the “Data Solution of the Year – Healthcare” award in the 2021 Data Breakthrough Awards. This is the second consecutive year that TrialAssure has earned this honor.
New TrialAssure LINK Technology Saves Up to 4 Weeks from Plain Language Summary Writing
TrialAssure released TrialAssure LINK, a software for the efficient development, review, translation and publishing of plain language, or lay summaries.
Support for Global Disclosure and Transparency Strategy and Implementation
Read our short case study on how TrialAssure supported a biotechnology company creating a global disclosure and transparency strategy.
Keeping Up with Changing Regulations
Our transparency experts published information on how Sponsors can prepare for the new EU Clinical Trial Regulation in January 2022.
- Why You Should Update Your Clinical Trial Disclosure Policy for the EU Clinical Trials Regulation and ICMJE Requirements Now
- EU Clinical Trials Regulation: The Need for Coordination by Sponsors
- Attention Sponsors, Be Prepared to Publish Your Interim Clinical Study Results
- How to Train Users on the Clinical Trial Information System (CTIS) Ahead of New Regulations
Expert Insight Webinars
Our TrialAssure team shared their expertise in two webinars this year.
Transparency: Effective Data and Document Anonymization at the Intersection of Process and Technology
Kelly Vaillant and Zach Weingarden shared how cutting-edge technology and data-driven processes combine to expedite anonymization of clinical artifacts, explored how machine learning techniques can be applied to accurately identify subject-identifying text in PDF documents, and evaluated risk assessment techniques, both qualitative and quantitative, with how they apply to each artifact.
EU Clinical Trials Regulation: The Clinical Trial Transparency Revolution
This webinar explored how the new CT Regulation impacts Sponsors and reviewed changes to clinical trials processes, protocols, informed consent for minors, and impacts to lay summaries.
Keep a look out for more TrialAssure webinars, articles and case studies coming in 2022.